| abstract |
Described herein are compounds and pharmaceutical compositions containing such compounds, which compounds and pharmaceutical compositions inhibit the activity of histone deacetylase 8 (HDAC8). Also described herein are such HDAC8 inhibitors, alone and in combination with other compounds, for treating patients suffering from a disease or condition that would benefit from inhibition of HDAC8 activity. This is a method using an HDAC8 inhibitor. [Selection] Figure 1 |